Mardil Medical today announced the first-in-human use of its VenTouch Triad ventricular reshaping device designed to treat patients with Type IIIb functional mitral valve regurgitation. The VenTouch Triad device, which is designed as a combination therapy to treat both the dilated ventricle and resulting distorted valve for FMR patients, was implanted in two patients with […]
Mardil Medical
Medtronic closes strategic investment in LifeTech | Wall Street Beat
Medtronic (NYSE:MDT) said it’s closed a $66 million investment in Chinese medical device company LifeTech Scientific (HK:8122).